SERES THERAPEUTICS

seres-therapeutics-logo

Seres Therapeutics is a clinical-stage biotherapeutic company that develops ecobiotic therapeutic products. They engaged in developing biological drugs which are referred to as ecobiotic microbiome therapeutics.

#SimilarOrganizations #People #Financial #Event #Website #More

SERES THERAPEUTICS

Social Links:

Industry:
Biopharma Biotechnology Health Care Therapeutics

Founded:
2010-01-01

Address:
Cambridge, Massachusetts, United States

Country:
United States

Website Url:
http://www.serestherapeutics.com

Total Employee:
251+

Status:
Active

Contact:
+1 617 945 9626

Email Addresses:
[email protected]

Total Funding:
402.8 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Wordpress Plugins Nginx Sitelinks Search Box


Similar Organizations

acrivon-therapeutics-logo

Acrivon Therapeutics

Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.

aimmune-therapeutics-logo

Aimmune Therapeutics

Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.

edgewise-therapeutics-logo

Edgewise Therapeutics

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.

nextcure-logo

NextCure

NextCure is a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs.

ribon-therapeutics-logo

Ribon Therapeutics

Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.


Current Advisors List

roger-pomerantz_image

Roger Pomerantz Senior Clinical Advisor to the Board of Directors @ Seres Therapeutics
Advisor
2019-12-01

greg-behar_image

Greg Behar Board of Director @ Seres Therapeutics
Board_member

Current Employees Featured

carlo-tanzi_image

Carlo Tanzi
Carlo Tanzi Vice President, Head of Investor Relations and Corporate Communications @ Seres Therapeutics
Vice President, Head of Investor Relations and Corporate Communications
2018-01-01

david-berry_image

David Berry
David Berry Founder @ Seres Therapeutics
Founder
2010-01-01

not_available_image

Eric Shaff
Eric Shaff CFO @ Seres Therapeutics
CFO

david-cooke_image

David Cooke
David Cooke CSO and Executive Vice President of R&D @ Seres Therapeutics
CSO and Executive Vice President of R&D

matthew-henn_image

Matthew Henn
Matthew Henn Executive VP, Chief Scientific Officer @ Seres Therapeutics
Executive VP, Chief Scientific Officer
2019-02-01

stephen-berenson_image

Stephen Berenson
Stephen Berenson Chairman Of The Board @ Seres Therapeutics
Chairman Of The Board
2019-08-01

jennifer-russo-wortman_image

Jennifer Russo Wortman
Jennifer Russo Wortman Vice President, R&D - Clinical Discovery & Research Technologies @ Seres Therapeutics
Vice President, R&D - Clinical Discovery & Research Technologies
2019-01-01

david-a-arkowitz_image

David A. Arkowitz
David A. Arkowitz CFO and Head of Business Development @ Seres Therapeutics
CFO and Head of Business Development
2021-06-01

paula-a-cloghessy_image

Paula A. Cloghessy
Paula A. Cloghessy EVP, Chief People Officer @ Seres Therapeutics
EVP, Chief People Officer
2022-02-07

david-berry_image

David Berry
David Berry Co-Founder @ Seres Therapeutics
Co-Founder

Founder


david-berry_image

David Berry

noubar-afeyan_image

Noubar Afeyan

Stock Details


Company's stock symbol is NASDAQ:MCRB

Investors List

ra-capital-management_image

RA Capital Management

RA Capital Management investment in Post-IPO Equity - Seres Therapeutics

carb-x_image

CARB-X

CARB-X investment in Grant - Seres Therapeutics

nestl-health-science_image

Nestlรฉ Health Science

Nestlรฉ Health Science investment in Series D - Seres Therapeutics

flagship-ventures_image

Flagship Pioneering

Flagship Pioneering investment in Series C - Seres Therapeutics

flagship-ventures_image

Flagship Pioneering

Flagship Pioneering investment in Series B - Seres Therapeutics

alexandria-venture_image

Alexandria Venture

Alexandria Venture investment in Series B - Seres Therapeutics

ensoventures_image

Enso Ventures

Enso Ventures investment in Series B - Seres Therapeutics

mayoclinic_image

Mayo Clinic

Mayo Clinic investment in Series B - Seres Therapeutics

ensoventures_image

Enso Ventures

Enso Ventures investment in Series A - Seres Therapeutics

flagship-ventures_image

Flagship Pioneering

Flagship Pioneering investment in Series A - Seres Therapeutics

Newest Events participated

south-summit-2017_event_image Participated in South Summit 2017 on 2017-10-04 as sponsor

Official Site Inspections

http://www.serestherapeutics.com Semrush global rank: 1.94 M Semrush visits lastest month: 11.12 K

  • Host name: 14.165.188.35.bc.googleusercontent.com
  • IP address: 35.188.165.14
  • Location: United States
  • Latitude: 38.6583
  • Longitude: -77.2481
  • Timezone: America/New_York

Loading ...

More informations about "Seres Therapeutics" on Search Engine